The binding of substrates and inhibitors to dihydrofolate reductase was studied by steady-state kinetics and high-field 'H-n.m.r. spectroscopy. A serius of 5-substituted 2,4-diaminopyrimidines were examined and were found to be 'tightly binding' inhibitots of the enzyme (Ki < 10-' M). Studies on the binding of 4-substituted benzenesulphonamides and benzenesulphonic acids also established the existence of a 'sulphonamide-binding site' on the enzyme. Subsequent n.m.r. experiments showed that there are two binding sites for the sulphonamides on the enzyme, one of which overlaps the coenzyme (NADPH) adeninering-binding site. An examination of the pH-dependence of the binding of sulphonamides to the enzyme indicated the influence of an ionizable group on the enzyme that was not directly involved in the sulphonamide binding. The change in pKa value from 6.7 to 7.2 observed on sulphonamide binding suggests
INTRODUCTION
Dihydrofolate reductase (DHFR) (tetrahydrofolate: NADP+ oxidoreductase, EC 1.5.1.3) is a ubiquitous enzyme that is the target for a number of clinically useful drugs, including methotrexate (MTX), trimethoprim (TMP) and pyrimethamine and their derivatives. Structure-activity relationships of the inhibitors of DHFR have been reviewed in detail (Blaney et al., 1984) . Antibacterial drugs of the 'antifolate' class (of which trimethoprim is an example) are often used in conjunction with sulphonamides, following the observation that such combinations are synergistic (Greenberg, 1949) . This effect has traditionally been explained on the basis of the two components binding independently to two enzymes on a linear metabolic pathway, namely dihydropteroate synthetase (EC 2.5.1.5) and DHFR (Potter, 1951) . However, subsequent workers have claimed that this is not an adequate explanation of the phenomenon (Rollo, 1955; Webb, 1963; Rubin et al., 1964; Wise & Aboudania, 1975) , and there is evidence to suggest that the synergism may be a result of simultaneous binding of the antifolate inhibitor and the sulphonamide to DHFR (Poe, 1976; Poe & Ruyle, 1981) .
The present study is designed to investigate and extend further this hypothesis by identifying the position of and residues involved in the sulphonamide-binding site of purified bacterial DHFR.
EXPERIMENTAL Materials
Escherichia coli M.R.E. 600 was obtained as a frozen cell suspension from the Centre for Applied Microbiology and Research, Porton Down, Wilts., U.K. Folic acid, MTX and NADPH were from Sigma Chemical Co., Poole, Dorset, U.K. Dihydrofolic acid was prepared by the method of Futterman (1957) as modified by Blakely (1960) , and stored as a suspension in 5 mM-HCl at -70 'C. All other reagents were of the highest purity commercially available and were used without further purification. Lactobacillus casei N.C.B. 6375 (MTX/R) DHFR was isolated and purified as described previously (Dann et al., 1976) .
Isolation of E. coli M.R.E. 600 DHFR M.R.E. 600 is a wild-type strain of E. coli, grown in the absence of any DHFR inhibitors, thus lacking elevated concentrations of the enzyme. This strain was chosen because of the ready availability of kilogram quantities of cultured cells, in addition to the fact that changes reported to arise in enzyme sequence/structure in response to the presence of DHFR inhibitors will not have occurred (Albrecht et al., 1972; Niethammer & Jackson, 1975; Flintoff et al., 1976; Jackson & Niethammer, 1977) .
The purification of DHFR from E. coli M.R.E. 600 was accomplished by using the procedure of Poe et at. (1972) , and included gel-filtration, ion-exchange and affinity-chromatography stages (see Table 1 for more details). The MTX-aminoethyl-Sepharose affinity resin used in the isolation was prepared as suggested by Cuatrecasas (1970) and Poe et al. (1972) . The protein concentration was measured at each stage during the purification by using the methods of Lowry et al. (1951) and of Warburg & Christian (1941) , with bovine serum albumin as standard. Throughout the purification, the enzyme activity was assessed by using a spectrophotometric assay adapted from Baccanari et al. (1975) . The assay was performed at 37.0 + 0.1 'C in 50 mM-Tris/HCl buffer, pH 7.2, containing 50 ,iM-dihydrofolate, 60 ,UM-NADPH, 50 mM-KCl, 10 mM-2-mercaptoethanol, 1 mM-EDTA and enzyme in a total volume of 3.00 ml. The decrease in absorbance at 340 nm was measured with a Pye-Unicam SP.8-100 spectrophotometer. A value of 12300 m-1 cm-' for the absorption coefficient of the reaction was used (Hillcoat et al., 1967) . One unit of enzyme activity is defined as the amount of enzyme required to reduce 1 umol of dihydrofolate/min under the stated conditions of pH and temperature. Synthesis and inhibitors MTX, TMP and N-(p-aminobenzoyl)-L-glutamic acid (p-ABG) were obtained from Sigma Chemical Co. 4-Nitrobenzenesulphonamide, n-propylbenzene, n-butylbenzene, 4-fluorobenzenesulphonyl chloride, 4-chlorobenzenesulphonyl chloride and 4-bromobenzenesulphonyl chloride were purchased from Aldrich Chemical Co. 4-Hydroxybenzenesulphonic acid was obtained as a 650 (w/v) solution from Fluorochem. 2,4-Diaminopyrimidine was synthesized according to the method of English & Clapp (1947) . TMP and p-ABG were recrystallized from water before use. MTX was used as obtained from Sigma Chemical Co.
The following 2,4-diaminopyrimidine derivatives were generously given by Dr. D. Warburton, May and Baker, Dagenham, Essex, U.K., and were all used without further purification: 2,4-diamino-6-methyl-5,3'-(3-nitrophenoxy)prop-1'-yloxypyrimidine (M&B 35902A), 2,4-diamino-6-methyl-5,3'-(2-trifluoromethylphenoxy)prop-'-yloxypyrimidine (M&B 38082A), 2,4-diamino-6-methyl-5,3'-(3-trifluoromethylphenoxy)prop-1'-yloxypyrimidine (M&B 35414), 2,4-diamino-6-ethyl-5,3'-(2-trifluoromethylphenoxy)prop-1'-yloxypyrimidine (M&B 39019), 2,4-diamino-6-ethyl-5,3'-(2-cyclohexylphenoxy)prop-l'-yloxypyrimidine (M&B 39434), 2,4-diamino-6-ethyl-5,3'-(2-trifluoromethyl-4-sulphonamid'ophenoxy)prop-l'-yloxypyrimidine hydrochloride (M&B 39568) and 2,4-diamino-5-hydroxy-6-methylpyrimidine (DEO 1693).
Sulphonamides and sulphonic acids were prepared by established methods (Scheifele & DeTar, 1963; Spryskov & Apar'eva, 1950; Clarke et al., 1963) .
RESULTS
The results for the purification of E. coli M.R.E. 600 DHFR are given in Table 1 . The percentage recovery and purification factors shown are lower limits, as a consequence of the inability to measure enzyme activity accurately in the two initial purification steps. This is thought to arise from the presence of nucleic acids, which are known to interfere with the enzyme assay (Hanngi & Littlefield, 1974) .
Electrophoresis of the purified enzyme on an SDS/ polyacrylamide gel showed a single band having an RF value of 0.74 + 0.02. Calibration with protein molecularmass markers gave a linear relationship between RF and log(molecular mass). The molecular mass calculated for DHFR was 21700+1300 Da. Measurements on a calibrated Sephadex G-75-50 column gave a closely similar value of 21 000 + 1000 Da. This value of approx. 21000 is in contrast with values of 17000 for DHFR from an MTX-resistant strain of E. coli (Poe et al., 1972) and 17800 for DHFR from a TMP-resistant strain of E. coli (Baccanari et al., 1975) among others (Mathews & Sutherland, 1965; Burchall & Hitchings, 1965; Erickson & Mathews, 1973) . It seems that the differences can be ascribed to the different bacterial strains used, similar differences having been noted for DHFR from different strains of L. casei (Dunlap et al., 1971; Dann et al., 1976) and Streptococcusfaecalis (Albrecht & Hutchinson, 1969; D'Souza et al., 1972) . General kinetic properties of the enzyme
The assay system used in all measurements of substrate/inhibitor binding was similar to that used during the enzyme purification. However, to overcome the problems often encountered with non-linear initial *reaction rates, the enzyme was preincubated with coenzyme (at a concentration of at least lOKm, i.e. 100uM) for a period of at least 5 min. Studies indicated that this preincubation time was sufficient to allow formation of the binary complex.
Values for the Km and Vm.x of the enzyme, as well as inhibitor Ki values, were calculated by using a weighted analysis (Cornish-Bowden, 1979) , and the enzyme concentration was measured from MTX titration. The values for the various kinetic parameters are given in These results indicate that the mode of action and K, value vary widely with substituent. However, the range of K1 values presented is broadly similar to that measured by Poe (1976) for an alternative series of sulphonamides. One noteworthy point of difference is that Poe (1976) found 4-aminobenzenesulphonamide (XVII) to be a competitive inhibitor (with respect to dihydrofolate, Ki = 24 x 10-3 M), whereas the present study indicated compound (XVII) to be a non-competitive inhibitor (Ki = 12 x 10-3 M). This finding is supported by the observation that inhibitors carrying a 4-NHR substituent [compounds (XVII), (XVIII) and (XXVI)] all exhibit non-competitive inhibition. In addition, it was found that under the assay conditions used 4-nitrobenzenesulphonamide (XIX) was partially reduced to compound (XVII). The mixed inhibition observed for compound (XIX) is thus assumed to be due to competitive inhibition arising from 4-nitrobenzensulphonamide, with a noncompetitive effect due to the 4-aminobenzenesulphonamide formed in the assay. It should be noted that the Ki+ for compound (XIX) is closely similar to the Ki for compound (XVII).
The similarity between the measured Ki values for the benzenesulphonamides and benzenesulphonic acids (Table 5) suggests that the major contribution to the binding energy of these compounds comes from the interaction of the aromatic portion of the inhibitor with the enzyme. In view of the large difference in charge state of the two classes of inhibitor at pH 7.2, an electrostatic interaction important for binding would be predicted to result in large differences in observed Ki values. This indicates that these inhibitors are not mimicking the p- ABG moiety of the substrate and forming an electrostatic interaction with arginine-57 (Kuyper et al., 1982) .
As an aid to determining the position and extent of the sulphonamide-binding site, the effect of different combinations of two inhibitors acting on the enzyme was monitored (see Table 6 for a list ofinhibitor combinations examined). Results obtained from the combination experiments were analysed according to the graphical methods described by Dixon & Webb (1979) and Yonetani & Theorell (1964) (Figs. 2 and 3 respectively) . Such experiments indicate whether a particular combination is synergistic (i.e. both inhibitors can bind simultaneously to the enzyme) or if the inhibitor binding is mutually exclusive. The binding of two synergistic, inhibitors to the enzyme can occur with either positive or negative co-operativity, the distinction being made according to the value of the inhibitor interaction factors, a and fi, obtained from the graphical analyses mentioned (Table 7) . a refers to the interaction of two competitive inhibitors (or a non-competitive inhibitor and substrate) and indicates the change in affinity of one inhibitor for the enzyme (as judged by its K, value) caused by the binding ofthe second. Similarly, , refers to the interaction of a competitive with a non-competitive inhibitor [see Segel (1975) in detail by the use of n.m.r. (Roberts et al., 1974; Way et al., 1975; Feeney et al., 1975 Feeney et al., , 1977a Birdsall et al., 1977a,b; Kimber et al., 1977 Kimber et al., , 1978 . A comparison of the effects of several inhibitors on both E. coli M.R.E. 600 DHFR and L. casei N.C.B. 6375 (MTX/R) DHFR is shown in Table 8 . For each inhibitor the mode of inhibition is identical, and the Ki values are closely similar for binding to both enzymes. It would thus appear that the mode of binding to the two enzymes is comparable, suggesting that it is possible to discuss directly the results of n.m.r. studies on the L. casei enzyme with the inhibition studies on the E. coli enzyme.
In the n.m.r. binding studies portions of 4-methylbenzenesulphonamide (XIII) were added to the L. casei enzyme at pH 6.5 in 500 mM-KCl/50 mM-KHPO4 solution. 1H-n.m.r. spectra were recorded at 500 MHz on a Bruker AM500 spectrometer, and the interaction was monitored via the chemical-shift changes in the C-2-H resonances of the imidazole rings of the histidine residues .
Titration of the enzyme with increasing concentrations of compound (XIII) produced two effects (Fig. 4) , the major effect corresponding to a large upfield shift in the resonance of HC, and a smaller upfield shift of HF. This is in comparison with the effect of p-ABG (IV) (Fig. 5) , which produces a similar upfield shift in HC but a large downfield shift in HF. From previous work with p-ABG , it has been established that the effect on HC (histidine-64) is due to binding of p-ABG (IV) in the adenine pocket of the coenzyme-binding site, whereas the effect on HF is due to binding in the benzoylglutamate-binding site used by dihydrofolate.
The results of a competition experiment involving titration of the preformed enzyme-compound (XIII) binary complex with p-ABG are shown (Fig. 6) . These data suggest that p-ABG and compound (XIII) share common binding sites in the vicinity of Hc and HF. However, the HF binding sites are non-identical, as evidenced by the absence of ring-current shifts on the aromatic protons of compound (XIII) when bound, compared with the substantial observed shifts in the aromatic protons of compound (IV) . From Fig. 6 6 x 10-12 1.8x 10-8+0.2x 10-8 2.6x 10-3+0.8x 10-3 3.9x 10-4+0.5x 10-4 1.2 x 10-2 +0. ]. The observed shifts of HF are markedly different, despite the close similarity ofthe Ka values for compounds (IV) and (XIII), suggesting that compound (XIII) does not interact directly with the imidazole ring of histidine-28. This is consistent with the distinct electronic differences between compounds (IV) and (XIII). It was not possible to estimate the Ka value for compound (XIII) at site C from the data in Fig. 6 . However, when 10 equivalents of either compound (IV) or compound (XIII) are added to the enzyme, H, is shifted by similar amounts (0.215 and 0.210 p.p.m. respectively), which suggests that the two ligands are binding fairly similarly at site C (similar binding constants and similar bound shifts would explain the data). As the binding of these ligands at site C is relatively weak [Ka for p-ABG at this site is 4.29 x 10 2+0.16 x lo-2 M ] compared with that for NADPH, this site can be considered to be unimportant in all measurements on inhibitor carried out in the presence of high concentrations of NADPH, as was the case in the spectrophotometric assay used in the E. coli binding studies. Effect of pH on sulphonamide binding to L. casei N.C.B. 6375 (MTX/R) DHFR The Ki values of compound (XIII), measured over the pH range 5.5-8.5 under conditions of ionic strength similar to those used for the n.m.r. studies, are shown (Fig. 7) . From these data, the pKa of the binding site in the free enzyme (pKE) and in the enzyme-inhibitor binary complex (pKEI) may be calculated. The values obtained were 6.67 and 7.33 respectively. These results would appear to implicate a histidine residue (or residues) in the pH-dependence of the sulphonamide binding [cf. a similar pKa shift of HF on the binding of compound (IV) was measured from n.m.r.: pKE = 6.54 and pKEI = 7.2 ]. This conclusion is supported by the n.m.r. titration of histidine C-2-H chemical shift as a (Jones, function of sulphonamide concentration (Fig. 4) 
